3.7
View the full transcript and gain access to JoVE Core videos
Q1: What is the structure of the plasma membrane and how does it function as a cellular barrier?
The plasma membrane is a highly ordered structure composed of phospholipids, carbohydrates, and proteins that protects the cell's integrity while enabling selective substance exchange. Phospholipids form a bilayer with hydrophilic heads facing outward and hydrophobic tails facing inward. Transmembrane proteins such as receptors, ion channels, structural anchors, and transporters intersperse these bilayers, conducting various cellular activities essential for drug transport and cell function.
Q2: How does passive diffusion enable drugs to cross cellular membranes?
Passive diffusion is the most prevalent drug transport mechanism, allowing drugs to move along their concentration gradient and cross the cell membrane without requiring energy. Drugs can traverse the membrane autonomously or with a transporter's assistance through facilitated diffusion. This process does not require ATP, making it energetically favorable for drugs with appropriate lipophilicity and molecular properties.
Q3: What is the difference between active transport and passive transport for drug movement?
Active transport moves drugs against their concentration gradient using ATP-powered transporters, requiring cellular energy expenditure. In contrast, passive transport moves drugs along their concentration gradient without energy input. Active transport is essential for drugs that cannot cross membranes passively due to their chemical properties or when higher intracellular concentrations are needed than the gradient would naturally allow.
Q4: What are the different pathways drugs can use to cross cellular barriers?
Drugs employ multiple pathways to cross cellular barriers. The transcellular pathway involves direct passage through the cell membrane via passive or active transport. The paracellular pathway allows drugs to traverse the gap between adjacent cells, bypassing the membrane entirely. Additionally, vesicular transport mechanisms enable movement through endocytosis and exocytosis, providing alternative routes for drugs that cannot cross membranes through conventional mechanisms.
Q5: What biological barriers must drugs overcome to reach their target sites?
Drugs encounter multiple barriers including the multi-layered skin, single-layered intestinal epithelium, and the plasma membrane. Each barrier presents distinct challenges based on its structure and composition. The skin's multiple layers provide significant resistance, while the intestinal epithelium's single layer is more permeable. The plasma membrane's selective permeability requires drugs to possess specific properties or utilize active transport mechanisms to achieve therapeutic concentrations at target sites.
Q6: How do transmembrane proteins facilitate drug transport across cell membranes?
Transmembrane proteins function as transporters, receptors, ion channels, and structural anchors that enable selective drug movement across the plasma membrane. These proteins facilitate both passive transport through facilitated diffusion and active transport powered by ATP. By providing specific binding sites and conformational changes, transmembrane proteins allow drugs to cross the hydrophobic lipid bilayer efficiently, even when the drug's chemical properties would otherwise prevent direct membrane passage.
Q7: Why is understanding drug transport mechanisms important for pharmacological treatment?
Understanding transport mechanisms is crucial for successful drug delivery and therapeutic efficacy. Different drugs require different transport pathways based on their chemical properties, molecular size, and charge. By comprehending whether a drug undergoes passive diffusion, active transport, or paracellular transport, pharmaceutical scientists can optimize drug formulations, predict absorption rates, and design delivery systems that maximize therapeutic effectiveness while minimizing adverse effects.